Stocksigma LogoStocksigma Logo

Fermenta Biotech Signs Exclusive License Agreement with VIT for Vitamin B12 Fortification

Fermenta Biotech signed an exclusive license agreement on 8th Sep'26 with Vellore Institute of Technology (VIT) to commercialize patent-pending technology

Fermenta Biotech Signs Exclusive License Agreement with VIT for Vitamin B12 Fortification

Fermenta Biotech Ltd 路 Press Release 路 08 Sept 2026, 10:34 pm

Fermenta Biotech Signs Exclusive License Agreement with VIT for Vitamin B12 Fortification Fermenta Biotech signed an exclusive license agreement on 8th Sep'26 with Vellore Institute of Technology (VIT) to commercialize patent-pending technology (Indian Patent Application No. 202441015300) for natural in-situ Vitamin B12 fortification in fermented foods. The process enriches Vitamin B12 directly during fermentation鈥攁pplicable to curd, batters, and breads鈥攊ntegrating seamlessly with existing manufacturing methods and retaining ~80% Vitamin B12 post-cooking. Fermenta aims to scale this innovation across FMCG, food and nutrition, and nutraceutical segments, advancing application development, regulatory evaluations, and commercial solutions.

Original exchange filing (PDF)

More announcements from Fermenta Biotech Ltd

All Fermenta Biotech Ltd announcements